Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Nautilus Biotechnology (NAUT) Accumulated Depreciation & Amortization (2020 - 2026)

Nautilus Biotechnology has reported Accumulated Depreciation & Amortization over the past 7 years, most recently at $8.5 million for Q1 2026.

  • Quarterly results put Accumulated Depreciation & Amortization at $8.5 million for Q1 2026, up 20.86% from a year ago — trailing twelve months through Mar 2026 was $8.5 million (up 20.86% YoY), and the annual figure for FY2025 was $8.1 million, up 24.29%.
  • Accumulated Depreciation & Amortization reached $8.5 million in Q1 2026 per NAUT's latest filing, up from $8.1 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $8.5 million in Q1 2026 and bottomed at $2.3 million in Q1 2022.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $5.1 million (2024), compared with a mean of $5.2 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization surged 239.9% in 2022 before it rose 20.86% in 2026.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $3.0 million in 2022, then soared by 56.4% to $4.6 million in 2023, then skyrocketed by 41.0% to $6.5 million in 2024, then grew by 24.29% to $8.1 million in 2025, then increased by 4.17% to $8.5 million in 2026.
  • Business Quant data shows Accumulated Depreciation & Amortization for NAUT at $8.5 million in Q1 2026, $8.1 million in Q4 2025, and $7.7 million in Q3 2025.